Cocrystal Pharma, Inc. (COCP) Misses Q3 EPS by 18c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.70), $0.18 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Goldman "broadly" raises estimates for LTL and truckload stocks
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance